about
Multigene testing of moderate-risk genes: be mindful of the missenseA covalently bound inhibitor triggers EZH2 degradation through CHIP-mediated ubiquitination.Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNA.Two decades after BRCA: setting paradigms in personalized cancer care and preventionBreast Cancer: Exploring the Facts and Holistic Needs during and beyond Treatment.Payer Coverage for Hereditary Cancer Panels: Barriers, Opportunities, and Implications for the Precision Medicine Initiative.Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family RegistryPrevalence of mutations in a panel of breast cancer susceptibility genes in BRCA1/2-negative patients with early-onset breast cancer.Screening for familial and hereditary prostate cancer.Cancer susceptibility syndromes in children in the area of broad clinical use of massive parallel sequencing.Liver cancer oncogenomics: opportunities and dilemmas for clinical applications.Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients With Suspected Lynch Syndrome.Exome sequencing reveals frequent deleterious germline variants in cancer susceptibility genes in women with invasive breast cancer undergoing neoadjuvant chemotherapyA comprehensive custom panel design for routine hereditary cancer testing: preserving control, improving diagnostics and revealing a complex variation landscapeGetting personal: Head and neck cancer management in the era of genomic medicine.Comprehensive detection of germline variants by MSK-IMPACT, a clinical diagnostic platform for solid tumor molecular oncology and concurrent cancer predisposition testing.Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast CancerHOXB13 and other high penetrant genes for prostate cancer.Oncologists' and cancer patients' views on whole-exome sequencing and incidental findings: results from the CanSeq studyDevelopment of a tiered and binned genetic counseling model for informed consent in the era of multiplex testing for cancer susceptibilityResearch participant interest in primary, secondary, and incidental genomic findings.Benchmarking of Whole Exome Sequencing and Ad Hoc Designed Panels for Genetic Testing of Hereditary Cancer.Unraveling tumor grading and genomic landscape in lung neuroendocrine tumors.DNA mutations of the cat: the good, the bad and the ugly.Lynch syndrome: five unanswered questions.Candidate DNA repair susceptibility genes identified by exome sequencing in high-risk pancreatic cancer.Cancer Genetic Counseling and Testing in an Era of Rapid Change.Germline genetic variants in men with prostate cancer and one or more additional cancers.Next-generation sequencing of a family with a high penetrance of monoclonal gammopathies for the identification of candidate risk alleles.The future of clinical cancer genomics.Tour de France Champions born or made: where do we take the genetics of performance?Gaps in Incorporating Germline Genetic Testing Into Treatment Decision-Making for Early-Stage Breast Cancer.Unsolicited findings of next-generation sequencing for tumor analysis within a Dutch consortium: clinical daily practice reconsidered.Evaluation of laboratory perspectives on hereditary cancer panels.Personal Genomic Testing for Cancer Risk: Results From the Impact of Personal Genomics Study.Identification of KANSARL as the first cancer predisposition fusion gene specific to the population of European ancestry origin.Elucidating the molecular basis of MSH2-deficient tumors by combined germline and somatic analysis.MAP: Mutation Arranger for Defining Phenotype-Related Single-Nucleotide Variant.Decision Making on Medical Innovations in a Changing Health Care Environment: Insights from Accountable Care Organizations and Payers on Personalized Medicine and Other Technologies.Decade in review--genomics: a decade of discovery in cancer genomics.
P2860
Q24658557-B0262064-B17D-4D3E-86CB-F0522F0D1F99Q33626131-D2126A05-D1EC-43F0-BCC0-82F34E3C2B20Q33817011-88322531-6F22-4D6B-90CC-F36A3F0E4492Q33820594-EE2DA14E-4C1D-4925-A4D9-3F28A49E7AD2Q33856007-417BAC9D-35F3-4BB6-9289-2158C80F6E17Q33900845-875D80B4-F918-4E91-9B58-9363205F7095Q35735103-936D0F73-85A3-4BCF-9132-86655F789A42Q35736188-2102CD3F-4F5F-48C9-86DD-50B13F2F8595Q35861576-A04587FB-DA8B-4BA2-B865-71AD71381696Q35894536-684BE58A-503D-4F62-9A19-D4F47FCFF848Q35913384-DE97976F-1601-4051-B693-EB4769E16B09Q35998356-9AF55B36-84C4-48DA-8AF2-FD2CF67B349DQ36025853-B092A99E-029C-415E-A60E-81E5B8025C5CQ36239238-C644B186-9851-4A96-93AC-5CF2EC40129EQ36303715-14742ED8-D886-440C-B4D7-4C0D361B5CE3Q36376718-2F71D08B-BA46-4504-A950-1992E61E0228Q36890898-C90CB36D-3BE4-45C0-93BC-FA8A134A6D9BQ37113171-8F413245-A4E9-495B-B656-B7EF77DC1E2AQ37168371-F8519A42-247C-4D3D-8D0E-DE68E215393AQ37172220-0D059824-52BA-40C2-BEF0-0AC5AC01EED6Q37358417-CD8C31A0-BFDC-4977-83CC-30A3523A4996Q37554531-1426DCDB-DDE7-4EE4-8B0A-03E959018277Q38207553-058C8D77-BCB3-4BA3-ADCF-2BB4CC0AC5C2Q38363409-2BB53C5B-D7C4-48EA-8EC6-CB1833B9719CQ38367449-352A2F80-8266-4B4E-8436-9E91DB962019Q38441095-38148B6A-B8E2-4BF0-9FDE-E80FFB7629B5Q38691948-81691C9A-0904-45F6-A765-AADDF33A674DQ38705089-04262FBE-7E7A-44A3-ACD9-1490D8D4B436Q38764731-ED2EE9B7-8DE6-4382-A33C-D36BEEB78E36Q38789283-FEB2D677-46B2-49A1-B1C9-79DE267BC58BQ38833709-D9DE502F-19BF-47B2-AF8D-BC56851FD477Q38840457-5A19EBAC-98AF-4B01-BC09-00AA7D56998CQ38882097-E3B36685-7233-4B4A-A2D2-575D94665E26Q38909157-0A515DA8-AFC3-4603-9493-03EF36921036Q39114110-D4628BC7-C479-4372-835D-1170A801BCCDQ40053323-DEB35B52-155B-485A-9941-093C9906FBACQ40174495-CE663549-BEB9-40E9-8BA5-093828412920Q41370030-94AA9C0E-0C69-45EA-9592-E5DE1BFB0658Q45966973-37C34228-792C-4948-A415-6B5FF3E2B097Q53229874-83F50B18-7748-4B2F-AE49-7EF969EDF07E
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Cancer genomics and inherited risk.
@en
type
label
Cancer genomics and inherited risk.
@en
prefLabel
Cancer genomics and inherited risk.
@en
P2860
P50
P356
P1476
Cancer genomics and inherited risk.
@en
P2093
Zsofia K Stadler
P2860
P304
P356
10.1200/JCO.2013.49.7271
P407
P577
2014-01-21T00:00:00Z